glp -1 six in one GLP-1 Agonists: A Comprehensive Overview Watch GLP-1 SIX-in-ONE Solution Oral

Habib AM, Richards P, Cairns LS, Rogers GJ, Bannon CAM, Parker HE, et al

11 The SELECT trial showed a 20% reduction in the risk of these events in adults with obesity and cardiovascular disease but no prior history of diabetes

The reason this concept has not yet been tested in the context of GLP-1 is because, until very recently, it was not possible to engineer microalgae and cyanobacteria

Health Free Cash Flow : -$3M (-$63M YoY) Free Cash Flow Margin : 0% (-12pp YoY, -13pp QoQ) TTM Free Cash Flow : $57M (-71% YoY) TTM Free Cash Flow Margin : 2% (-11pp YoY, -3pp QoQ) Operating Cash Flow was $61M, down 29% YoY, likely due to shorter shipping cadences in the Weight Loss business